missing translation for 'onlineSavingsMsg'
Learn More

Tocris Bioscience™ LEI 401

Catalog No. 740710
Change view
Click to view available options
Quantity:
10 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
740710 10 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 740710 Supplier Tocris Bioscience™ Supplier No. 7407/10*
Only null left

High affinity N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) inhibitor

LEI 401 is a high affinity N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) inhibitor (Ki = 0.027 and 0.18 μM for human and mouse NAPE-PLD, respectively; IC50 for human enzyme = 0.86 μM). LEI 401 exhibits no significant activity at cannabinoid receptors or other metabolic enzymes of the endocannabinoid system. The product reduces levels of N-acylethanolamines (NAE) in a neuroblastoma cell line in vitro. It also reduces anandamide levels in mouse brain in vivo and impairs fear extinction. LEI 701 is CNS penetrant and cell-permeable.

Specifications

Chemical Name or Material N-(Cyclopropylmethyl)-6-[(3 S)-3-hydroxy-1-pyrrolidinyl]-2-[(3 S)-3-phenyl-1-piperidinyl]-4-pyrimidinecarboxamide
CAS 2393840-15-6
Quantity 10 mg
Target Phospholipase Inhibitors
Molecular Formula C24H31N5O2
Purity 0.98